Payments for Pathology


Reimbursements made by insurers affect your pay, and resources. The CAP intrinsically ensures adequate representation for coverage and reimbursement issues facing pathologists in the legislative and regulatory landscape. We represent pathologists’ interests in nearly every payment-related policy discussion, including:

  • The only pathologist organization on the American Medical Association (AMA) Relative Value Scale Update Committee (RUC), a committee that recommends what Medicare and most private insurers pay for physician services.
  • Representatives on councils across the country that advise on local coverage determinations (LCDs) by insurers, so pathologists are appropriately reimbursed for medically reasonable and necessary services.
  • Staff advocating on your behalf on the Medicare fee schedule via submission of formal comments and face-to-face meetings.

Producing Results that Matter

CAP Advocacy Success:
Past Effects on Medicare Payments

Through our advocacy to protect the value of pathology services, overall Medicare payments to pathologists are projected to increase between 2017 and 2018. Due to the CAP’s engagement with the CMS and other stakeholders, our advocacy achieved positive changes, resulting in increases in payment for pathology services between the proposed and final Medicare Physician Fee Schedule (PFS) rulemakings (see graph). Without the CAP’s advocacy on Medicare payment, it was estimated that reimbursements from Medicare to pathologists in the final rules would have been $15 million lower over the two years. Read more in our Annual Report.